TsugafolinCAS# 66568-97-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 66568-97-6 | SDF | Download SDF |
| PubChem ID | 45273057 | Appearance | Powder |
| Formula | C17H16O5 | M.Wt | 300.3 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S)-7-hydroxy-5-methoxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one | ||
| SMILES | COC1=CC=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)OC | ||
| Standard InChIKey | KFGFEKHSEPSVNO-AWEZNQCLSA-N | ||
| Standard InChI | InChI=1S/C17H16O5/c1-20-12-5-3-10(4-6-12)14-9-13(19)17-15(21-2)7-11(18)8-16(17)22-14/h3-8,14,18H,9H2,1-2H3/t14-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Tsugafolin has weak anti-HIV activity. |
| Targets | HIV |
Tsugafolin Dilution Calculator
Tsugafolin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.33 mL | 16.65 mL | 33.3 mL | 66.6001 mL | 83.2501 mL |
| 5 mM | 0.666 mL | 3.33 mL | 6.66 mL | 13.32 mL | 16.65 mL |
| 10 mM | 0.333 mL | 1.665 mL | 3.33 mL | 6.66 mL | 8.325 mL |
| 50 mM | 0.0666 mL | 0.333 mL | 0.666 mL | 1.332 mL | 1.665 mL |
| 100 mM | 0.0333 mL | 0.1665 mL | 0.333 mL | 0.666 mL | 0.8325 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- ent-3beta-Hydroxykaur-16-en-19-oic acid
Catalog No.:BCN6472
CAS No.:66556-91-0
- CL 218872
Catalog No.:BCC7162
CAS No.:66548-69-4
- Augustifolin
Catalog No.:BCN3232
CAS No.:66548-01-4
- Ansamitocin P-3
Catalog No.:BCN8373
CAS No.:66547-09-9
- Propacetamol hydrochloride
Catalog No.:BCC9129
CAS No.:66532-86-3
- Benzoin isopropyl ether
Catalog No.:BCC8856
CAS No.:6652-28-4
- MSOP
Catalog No.:BCC6801
CAS No.:66515-29-5
- Bicifadine hydrochloride
Catalog No.:BCC7925
CAS No.:66504-75-4
- Amantadine HCl
Catalog No.:BCC4465
CAS No.:665-66-7
- JW 55
Catalog No.:BCC2453
CAS No.:664993-53-7
- H-D-Lys(Boc)-OMe.HCl
Catalog No.:BCC2990
CAS No.:66494-53-9
- Kaempferol 3-O-(6''-O-acetyl)glucoside-7-O-rhamnoside
Catalog No.:BCN1385
CAS No.:66465-24-5
- Forskolin
Catalog No.:BCN2332
CAS No.:66575-29-9
- Dihydrorotenone
Catalog No.:BCN2726
CAS No.:6659-45-6
- Agaric acid
Catalog No.:BCC9216
CAS No.:666-99-9
- Boc-Phenylalaninol
Catalog No.:BCC2718
CAS No.:66605-57-0
- RU 24969
Catalog No.:BCC5423
CAS No.:66611-26-5
- Risperidone hydrochloride
Catalog No.:BCC4205
CAS No.:666179-74-4
- Risperidone mesylate
Catalog No.:BCC4206
CAS No.:666179-96-0
- 2',4'-Dihydroxy-3,7':4,8'-diepoxylign-7-ene
Catalog No.:BCN6645
CAS No.:666250-52-8
- GW842166X
Catalog No.:BCC4413
CAS No.:666260-75-9
- Biotin Hydrazide
Catalog No.:BCC3582
CAS No.:66640-86-6
- Acetyl Angiotensinogen (1-14), porcine
Catalog No.:BCC1023
CAS No.:66641-26-7
- N-trans-Feruloyltyramine
Catalog No.:BCN4213
CAS No.:66648-43-9
(Rel)-1beta,2alpha-di-(2,4-dihydroxy-6-methoxybenzoyl)-3beta, 4alpha-di-(4-methoxyphenyl)-cyclobutane and other flavonoids from the aerial parts of Goniothalamus gardneri and Goniothalamus thwaitesii.[Pubmed:11140605]
Phytochemistry. 2000 Nov;55(5):439-46.
The aerial parts of Goniothalamus gardneri (Annonaceae) has yielded the known flavonoids 2'-hydroxy-4,4',6'-trimethoxychalcone (flavokawain A), 2',4'-dihydroxy-4,6'-dimethoxydihydrochalcone, 4,2',4'-trihydroxy-6'-methoxydihydrochalcone, 5,7,4'-trimethoxyflavanone (naringenin trimethyl ether) and 7-hydroxy-5,4'-dimethoxyflavanone (Tsugafolin) together with three novel compounds, the dimer characterised as (rel)-1beta,2alpha-di-(2,4-dihydroxy-6-methoxybenzoyl)-3beta,4alpha-di-(4-methoxy phenyl)-cyclobutane, 2',4'-dihydroxy-4,6'-dimethoxychalcone and 2'-hydroxy-4,4',6'-trimethoxydihydrochalcone. The last two have previously been synthesised but appear to be new natural products. A similar study of the aerial parts of G. thwaitesii led only to the isolation of the known flavonoids myricetin 4'-O-methyl ether-3-O-alpha-L-rhamnopyranoside (mearnsitrin) and myricetin-3-O-methyl ether (annulatin), together with the triterpenes friedelinol, friedelin and betulinic acid. All compounds were identified by spectroscopic analysis and, for known compounds, by comparison with published data.
Bioactive compounds from Vitex leptobotrys.[Pubmed:24404757]
J Nat Prod. 2014 Mar 28;77(3):663-7.
A new lignan, vitexkarinol (1), as well as a known lignan, neopaulownin (2), a known chalcone, 3-(4-hydroxyphenyl)-1-(2,4,6-trimethoxyphenyl)-2-propen-1-one (3), two known dehydroflavones, Tsugafolin (4) and alpinetin (5), two known dipeptides, aurantiamide and aurantiamide acetate, a known sesquiterpene, vemopolyanthofuran, and five known carotenoid metabolites, vomifoliol, dihydrovomifoliol, dehydrovomifoliol, loliolide, and isololiolide, were isolated from the leaves and twigs of Vitex leptobotrys through bioassay-guided fractionation. The chalcone (3) was found to inhibit HIV-1 replication by 77% at 15.9 muM, and the two dehydroflavones (4 and 5) showed weak anti-HIV activity with IC50 values of 118 and 130 muM, respectively, while being devoid of cytotoxicity at 150 muM. A chlorophyll-enriched fraction of V. leptobotrys, containing pheophorbide a, was found to inhibit the replication of HIV-1 by 80% at a concentration of 10 mug/mL. Compounds 1 and 3 were further selected to be evaluated against 21 viral targets available at NIAID (National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA).
